APA (7th ed.) Citation

Garelnabi, E. A. E., Pletsas, D., Li, L., Kiakos, K., Karodia, N., Hartley, J. A., . . . Wheelhouse, R. T. (2012). Strategy for Imidazotetrazine Prodrugs with Anticancer Activity Independent of MGMT and MMR. ACS medicinal chemistry letters, 3(12), 965-968. https://doi.org/10.1021/ml300132t

Chicago Style (17th ed.) Citation

Garelnabi, Elrashied A. E., Dimitrios Pletsas, Li Li, Konstantinos Kiakos, Nazira Karodia, John A. Hartley, Roger M. Phillips, and Richard T. Wheelhouse. "Strategy for Imidazotetrazine Prodrugs with Anticancer Activity Independent of MGMT and MMR." ACS Medicinal Chemistry Letters 3, no. 12 (2012): 965-968. https://doi.org/10.1021/ml300132t.

MLA (9th ed.) Citation

Garelnabi, Elrashied A. E., et al. "Strategy for Imidazotetrazine Prodrugs with Anticancer Activity Independent of MGMT and MMR." ACS Medicinal Chemistry Letters, vol. 3, no. 12, 2012, pp. 965-968, https://doi.org/10.1021/ml300132t.